Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; September 2022, Vol. 10 Issue: 9 p888-899, 12p
- Subject
- Language
- ISSN
- 22132600; 22132619